Showing results (41-50 of 70) with videos related to
Sort By:
Pageof 7
Journal of the National Cancer Institute|November 23, 2020
Poverty and Targeted Immunotherapy: Survival in Children's Oncology Group Clinical Trials for High-Risk NeuroblastomaKira Bona, Yimei Li, Lena E Winestone, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 5, 2021
Expenditures in Young Adults with Hodgkin Lymphoma: NCI-Designated Comprehensive Cancer Centers versus Other SitesJulie A Wolfson, Smita Bhatia, Jill P Ginsberg, et al.American Journal of Hematology|November 19, 2016
The role of acuity of illness at presentation in early mortality in black children with acute myeloid leukemiaLena E Winestone, Kelly D Getz, Tamara P Miller, et al.Pediatric Blood & Cancer|June 12, 2024
Time to diagnosis among young patients with cancerLena E Winestone, Jennifer J Wilkes, Diane Puccetti, et al.Transplantation and Cellular Therapy|April 17, 2024
Diagnosing and Grading of Sinusoidal Obstructive Syndrome after Hematopoietic Stem Cell Transplant of Children, Adolescent and Young Adults treated in a Pediatric Institution with Pediatric ProtocolsGabriel Salinas Cisneros, Christopher C Dvorak, Janel Long-Boyle, et al.Pediatric Blood & Cancer|October 19, 2023
Racial and ethnic disparities in acuity of presentation among children with newly diagnosed acute leukemiaLena E Winestone, Kelly D Getz, Yimei Li, et al.Pediatric Blood & Cancer|September 6, 2024
Multilevel challenges to equitable inclusion of children in trials when parents use languages other than English: A qualitative report from Children's Oncology Group's Diversity and Health Disparities Committee Language Equity Working GroupSheila Judge Santacroce, Melissa P Beauchemin, Wendy Pelletier, et al.Transplantation and Cellular Therapy|December 9, 2025
Fludarabine Pharmacokinetic Model-Based Dosing Minimizes the Risk of Graft Rejection in Pediatric Patients Undergoing Allogeneic Hematopoietic Cell TransplantationChristopher C Dvorak, Ella Waters, William C Temple, et al.Pediatric Blood & Cancer|May 12, 2020
Identifying relapses and stem cell transplants in pediatric acute lymphoblastic leukemia using administrative data: Capturing national outcomes irrespective of trial enrollmentViviane C Cahen, Yimei Li, Kelly D Getz, et al.Transplantation and Cellular Therapy|March 26, 2023
Access to Chimeric Antigen Receptor T Cell Clinical Trials in Underrepresented Populations: A Multicenter Cohort Study of Pediatric and Young Adult Acute Lymphobastic Leukemia PatientsAnurekha G Hall, Lena E Winestone, Erin M Sullivan, et al.Pageof 7